Mingxiao Yin

615 total citations
12 papers, 475 citations indexed

About

Mingxiao Yin is a scholar working on Immunology, Oncology and Molecular Biology. According to data from OpenAlex, Mingxiao Yin has authored 12 papers receiving a total of 475 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Immunology, 5 papers in Oncology and 4 papers in Molecular Biology. Recurrent topics in Mingxiao Yin's work include Cancer Immunotherapy and Biomarkers (5 papers), Immune Cell Function and Interaction (4 papers) and interferon and immune responses (2 papers). Mingxiao Yin is often cited by papers focused on Cancer Immunotherapy and Biomarkers (5 papers), Immune Cell Function and Interaction (4 papers) and interferon and immune responses (2 papers). Mingxiao Yin collaborates with scholars based in China. Mingxiao Yin's co-authors include Hongbin Deng, Xiaojia Liu, Jingwen Dong, Danqing Song, Qingxuan Zeng, Genxiang Mao, Yang Liu, Lu Liu, Na Zhang and Lu Liu and has published in prestigious journals such as The FASEB Journal, Journal of Medicinal Chemistry and Cell Death and Differentiation.

In The Last Decade

Mingxiao Yin

12 papers receiving 472 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Mingxiao Yin China 9 200 181 157 63 61 12 475
Liyan Qu China 8 253 1.3× 143 0.8× 99 0.6× 40 0.6× 126 2.1× 14 584
Sunyi Lee South Korea 13 201 1.0× 120 0.7× 80 0.5× 78 1.2× 34 0.6× 28 437
Suneetha Amara United States 12 167 0.8× 86 0.5× 103 0.7× 37 0.6× 18 0.3× 23 424
Ajeet Kumar Verma India 11 187 0.9× 72 0.4× 58 0.4× 33 0.5× 38 0.6× 16 349
Noha A. Amin Egypt 12 267 1.3× 51 0.3× 65 0.4× 82 1.3× 22 0.4× 13 472
Benjamin Lefkove United States 10 234 1.2× 61 0.3× 84 0.5× 41 0.7× 22 0.4× 10 473
Johnie Hodge United States 8 179 0.9× 87 0.5× 134 0.9× 44 0.7× 19 0.3× 10 372

Countries citing papers authored by Mingxiao Yin

Since Specialization
Citations

This map shows the geographic impact of Mingxiao Yin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mingxiao Yin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mingxiao Yin more than expected).

Fields of papers citing papers by Mingxiao Yin

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mingxiao Yin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mingxiao Yin. The network helps show where Mingxiao Yin may publish in the future.

Co-authorship network of co-authors of Mingxiao Yin

This figure shows the co-authorship network connecting the top 25 collaborators of Mingxiao Yin. A scholar is included among the top collaborators of Mingxiao Yin based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mingxiao Yin. Mingxiao Yin is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

12 of 12 papers shown
1.
Wu, Yu, et al.. (2025). Enhancing NK Cell Antitumor Activity With Natural Compounds: Research Advances and Molecular Mechanisms. Phytotherapy Research. 39(5). 1905–1929. 1 indexed citations
2.
Wang, Yuting, Liping Li, Cuicui Sun, et al.. (2025). Daurisoline Modulates the TBK1-Dependent Type I Interferon Pathway to Boost Anti-tumor Immunity via Targeting of LRP1. Research. 8. 764–764. 1 indexed citations
3.
Yin, Mingxiao, Jingwen Dong, Cuicui Sun, et al.. (2023). Raddeanin A Enhances Mitochondrial DNA‐cGAS/STING Axis‐Mediated Antitumor Immunity by Targeting Transactive Responsive DNA‐Binding Protein 43. Advanced Science. 10(13). e2206737–e2206737. 33 indexed citations
4.
Liu, Xiaojia, Na Zhang, Jingwen Dong, et al.. (2023). USP2 promotes tumor immune evasion via deubiquitination and stabilization of PD-L1. Cell Death and Differentiation. 30(10). 2249–2264. 34 indexed citations
5.
Sun, Chengliang, Mingxiao Yin, Yao Cheng, et al.. (2022). Novel Small-Molecule PD-L1 Inhibitor Induces PD-L1 Internalization and Optimizes the Immune Microenvironment. Journal of Medicinal Chemistry. 66(3). 2064–2083. 33 indexed citations
6.
Liu, Xiaojia, Mingxiao Yin, Jingwen Dong, et al.. (2021). Tubeimoside-1 induces TFEB-dependent lysosomal degradation of PD-L1 and promotes antitumor immunity by targeting mTOR. Acta Pharmaceutica Sinica B. 11(10). 3134–3149. 61 indexed citations
7.
Liu, Yang, Xiaojia Liu, Mingxiao Yin, et al.. (2020). Berberine diminishes cancer cell PD-L1 expression and facilitates antitumor immunity via inhibiting the deubiquitination activity of CSN5. Acta Pharmaceutica Sinica B. 10(12). 2299–2312. 173 indexed citations
8.
Ding, Jinfeng, Liang Peng, Dejun Liu, et al.. (2020). Remedial Application of Urea Eliminates Yield Losses in Wheat Waterlogged during Stem Elongation. Agriculture. 10(1). 23–23. 8 indexed citations
9.
Zhang, Na, Lu Liu, Xin Zhang, et al.. (2019). SA-49, a novel aloperine derivative, induces MITF-dependent lysosomal degradation of PD-L1. EBioMedicine. 40. 151–162. 63 indexed citations
10.
11.
12.
Hu, Qingting, et al.. (2017). Efficacy and safety of antiepileptic drugs for refractory partial-onset epilepsy: a network meta-analysis. Journal of Neurology. 265(1). 1–11. 34 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Liyan Qu Breakdown of academic impact, for papers by Sunyi Lee Breakdown of academic impact, for papers by Suneetha Amara Breakdown of academic impact, for papers by Ajeet Kumar Verma Breakdown of academic impact, for papers by Noha A. Amin Breakdown of academic impact, for papers by Benjamin Lefkove Breakdown of academic impact, for papers by Johnie Hodge
Rankless by CCL
2026